EXECUTIVE ENGAGEMENTS
POOL
582
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
116
Interactions with Platform & by Email
PARTICIPANTS
23
Unique # Participated
VALIDATIONS
9
Responses Validated*
COMPANIES
22
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
54
PAGES
106
EDITION
17
PRICE
USD 5450
CODE
MCP-1831
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Biodefense estimated at US$13.5 Billion in the year 2020, is projected to reach a revised size of US$19.5 Billion by 2027, growing at aCAGR of 5.4% over the period 2020-2027. Vaccines, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$12.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biothreat Detection Devices segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
The Biodefense market in the U.S. is estimated at US$4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
SELECT PLAYERS
Achaogen, Inc.; Alexeter Technologies, LLC; Alnylam Pharmaceuticals, Inc.; Altimmune, Inc.; ANP Technologies, Inc.; Bavarian Nordic A/S; Cleveland BioLabs, Inc.; Elusys Therapeutics, Inc.; Emergent BioSolutions, Inc.; Ichor Medical Systems, Inc.; New Horizons Diagnostic Corporation; PathSensors, Inc.; Research International, Inc.; SIGA Technologies
SEGMENTS
» Product (Vaccines, and Biothreat Detection Devices)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Biothreat Detection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Biothreat Detection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Biothreat Detection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| USA Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| USA 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Canada Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Canada 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Japan Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Japan 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| CHINA |
| China Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| China Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| China 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| Europe Historic Review for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Europe 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027 |
| Europe Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Europe Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| FRANCE |
| France Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| France Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| France 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Germany Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Germany 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Italy Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Italy 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| UK Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| UK 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Rest of Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Rest of World Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Rest of World 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 22 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com